Subcutaneous treprostinil for the treatment of severe, non-operable chronic thromboembolic pulmonary hypertension: a randomized, double-blind, controlled study (CTREPH)
Sadushi-Kolici, R., Jansa, P., Torbicki, A., Hoffken, G., Skoro-Sajer, N., Klepetko, W., Lindner, J., Lang, I. M.Volume:
34
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/eht308.1065
Date:
August, 2013
File:
PDF, 53 KB
english, 2013